Skip to main content

Opening the CAR(T) Door to Get Your Patients to Therapy

Part 4 of 4 in a series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes

Click Here to Participate 

CE Activity Release Date: April 8, 2022
CE Activity Expiration Date: April 8, 2023 
Time to Complete Activity: 30 minutes
0.5 CME/CE Credit/Contact Hour for physicians, registered nurses, pharmacists, physician assistants, and case managers.


Target Audience

This CE activity is intended for hematologists-oncologists, fellows, NPs, PAs, nurses, pharmacists, navigators, case managers engaged in the care of patients with R/R B-cell lymphomas.



Opening the CAR(T) door to get your patients to therapy, the final episode of the 4-part educational initiative The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes, is designed for community-based oncology clinicians. This CE activity includes conversations among CAR-T experts and a community clinician; it includes patient video clips and numerous downloadable resources including a directory of CAR-T treatment centers organized by state.

This activity focuses on improving access to CAR-T therapy for patients regardless of geography or socioeconomic status, including common misperceptions, how to overcome barriers including financial ones, and the need for earlier referral. 


Educational Objectives

After completing this CE activity, the participant should be better able to:

  • Recognize common misperceptions regarding logistics of CAR-T 
  • Refer patients for consultation to determine if they are candidates for CAR-T earlier in the treatment journey
  • Identify and use resources to address logistical challenges related to CAR-T



Sergio A. Giralt, MD, FACP
Melvin Berlin Family Chair in Myeloma Research
Professor of Medicine
Weill Cornell Medical College
Deputy Head, Division of Hematologic Malignancies
Attending Physician, Adult BMT Service 
Memorial Sloan Kettering Cancer Center
New York, NY

Sanjay K. Juneja, MD
Hematology, Medical Oncology
Chief of Oncology Line            
Baton Rouge General Hospital
Mary Bird Perkins Cancer Center
Baton Rouge, LA

Rayne H. Rouce, MD, BS
Associate Professor
Department of Pediatrics
Texas Children’s Cancer Center for Cell and Gene Therapy
Baylor College of Medicine
Houston, TX


Neena Kennedy, BSN, RN, OCN™
Clinical Trial Nurse Navigator
The Leukemia & Lymphoma Society 
Rye Brook, NY

Alejandro Marinos-Velarde, MD
Hematology-Oncology Fellow
Baylor College of Medicine
Houston, TX

Elizabeth A. Weber, BSN, RN
Commercial Cellular Therapy Coordinator
University of Pennsylvania Health System
Philadelphia, PA


Educational Partner Statement & CME/CE Accreditation

This activity is developed with our educational partner, Medical Learning Institute, Inc.

In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society.   Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is certified for 0.5 credit/contact hour for physicians, registered nurses, pharmacists, physician assistants, and case managers.


Support Statement

This activity is supported by an independent educational grant from Bristol Myers Squibb.


Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. 


For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at